Company Information

  

Address: 9635 GRANITE RIDGE DRIVE, SUITE 100  
City: SAN DIEGO 
State: CA 
Zip Code: 92123 
Telephone: 858-459-7800 

Description of Business

Primary SIC Code: 3826
(As filed with the SEC)  

We are a therapeutic technology company focused on addressing unmet needs in global health and biodefense. In the field of infectious disease therapeutics, a majority of viruses that transmit human infections are not addressed with approved antiviral therapies. To address this significant unmet need, the Aethlon Hemopurifier┬« is an affinity hemofiltration device developed for the single-use elimination of life-threatening viruses from the human circulatory system. In the United States, we are advancing the Hemopurifier under a "Breakthrough Device" designation from The United States Food and Drug Administration (FDA). Under the "Breakthrough Device" program, the FDA has permitted the proposed "Indication for Use" for our device to include: "The Hemopurifier is a single-use device indicated for the treatment of life-threatening glycosylated viruses that are not addressed with an approved therapy.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-0.46NAN/E
12/2017-0.62NAN/E
09/2017-0.72NAN/E
06/2017-0.87NAN/E
03/2017-0.94NAN/E
12/2016-0.88NAN/E
09/2016-0.89NAN/E
06/2016-0.76NAN/E

Key Financial Ratios and Statistics

FYE: 03/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity-0.05Total Liab/Total Assets0.17
Net Inc/Total Assets-0.77Total Liab/Inv Cap0.18
Net Inc/Inv Cap-0.83Total Liab/Comm Equity0.01
Pretax Inc/Net Sales-38.09Interest Coverage Ratio-14.76
Net Inc/Net Sales-37.96Curr Debt/EquityNA
Cash Flow/Net Sales-26.14LTD/Equity0.14
SG&A/NetSales33.29Total Debt/Equity0.14
Asset Utilization   Liquidity  
Net Receivables Turnover4.00Quick Ratio15.13
Inventory TurnoverNACurrent Ratio15.13
Inventory Day SalesNANet Rec/Curr Assets0.01
Net Sales/Work Cap0.02Inv/Curr AssetsNA
Net Sales/PP&E5.43  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 0.07 0.07 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.35 1.24 1.24 1.16
Operating Income -1.27 -1.16 -1.24 -1.16
Interest Exp 0.06 0.06 0.06 0.19
Pretax Income -1.33 -1.22 -1.31 -1.85
Other Income -0.00 0.00 -0.01 -0.50
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -1.32 -1.22 -1.30 -1.84

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 6.97 5.61 0.92 0.33
Receivables - Total 0.07 NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 7.23 5.63 1.01 0.37
Net Property, Plant & Equipment 0.03 0.03 0.04 0.05
Total Assets 7.35 5.75 1.15 0.51
Liabilities        
Accounts Payable 0.21 0.28 0.32 0.33
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 0.48 0.34 0.35 0.41
Long-Term Debt 0.84 0.81 0.78 1.05
Total Liabilities 1.22 1.05 1.04 1.37
Stockholder's Equity        
Minority Interest -0.10 -0.09 -0.09 -0.08
Preferred Stock NA NA NA NA
Common Stock 0.02 0.02 0.01 0.01
Retained Earnings -99.46 -98.14 -96.92 -95.62
Treasury Stock NA NA NA NA
Total Stockholders' Equity 6.13 4.70 0.11 -0.87
Total Liabilities and Stockholders' Equity 7.35 5.75 1.15 0.51

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -1.02 -0.79 -1.03 -1.07
Net Cash Provided by Investing Activities -0.00 0.00 0.00 -0.02
Net Cash Provided by Financing Activities 2.38 5.48 1.62 -0.13

Annual Summary Data (Millions)

Year Sales Net Income EPS
03/20141.62-13.36--
03/20150.76-6.80--
03/20160.89-4.87-0.66
03/20170.39-7.28-0.94
03/20180.15-5.68-0.46
Growth Rates-44.90----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18211,2637.11




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.